{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06525077",
            "orgStudyIdInfo": {
                "id": "CLFT218-2401"
            },
            "organization": {
                "fullName": "Avadel",
                "class": "INDUSTRY"
            },
            "briefTitle": "Safety and Efficacy of FT218 in Idiopathic Hypersomnia (REVITALYZ)",
            "officialTitle": "A Double-blind, Placebo-controlled, Randomized Withdrawal, Multicenter Study of the Efficacy and Safety of FT218 in the Treatment of Idiopathic Hypersomnia (IH) With an Open-Label Safety Extension",
            "therapeuticArea": [
                "Other"
            ],
            "study": "safety-and-efficacy-of-in-idiopathic-hypersomnia-revitalyz"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-08",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-02",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-09",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-07-18",
            "studyFirstSubmitQcDate": "2024-07-23",
            "studyFirstPostDateStruct": {
                "date": "2024-07-29",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-23",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-29",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Avadel",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a double-blind, placebo-controlled, randomized withdrawal, multicenter study of the efficacy and safety of FT218 with an open-label safety extension period. FT218 drug product is a once-nightly formulation of sodium oxybate for extended-release oral suspension. The study will enroll subjects who are diagnosed with idiopathic hypersomnia. Subjects will be eligible to enroll regardless of current treatment with oxybate therapy or stimulants/alerting agents at study entry. The estimated total duration of study for each subject is approximately 42 weeks, including the open-label safety extension period."
        },
        "conditionsModule": {
            "conditions": [
                "Idiopathic Hypersomnia"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "maskingDescription": "For the double-blind, randomized withdrawal portion of the study, the subject and all members of the study team will remain blinded to treatment assignment.",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 150,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "FT218",
                    "type": "EXPERIMENTAL",
                    "description": "FT218 at stable dose (selected during earlier titration) administered orally once nightly",
                    "interventionNames": [
                        "Drug: FT218"
                    ]
                },
                {
                    "label": "Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Placebo equivalent administered orally once nightly",
                    "interventionNames": [
                        "Other: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "FT218",
                    "description": "Sodium oxybate for extended-release oral suspension",
                    "armGroupLabels": [
                        "FT218"
                    ],
                    "otherNames": [
                        "LUMRYZ"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Placebo",
                    "description": "Matched placebo equivalent for oral suspension",
                    "armGroupLabels": [
                        "Placebo"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Epworth Sleepiness Scale (ESS)",
                    "description": "Change in total ESS score",
                    "timeFrame": "End of stable dose visit to end of double-blind, randomized withdrawal visit [Week 12 to Week 14; 2 week period]"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Patient Global Impression of change (PGI-C)",
                    "description": "Worsening of idiopathic hypersomnia symptoms as assessed by subject",
                    "timeFrame": "End of stable dose visit to end of double-blind, randomized withdrawal visit [Week 12 to Week 14; 2 week period]"
                },
                {
                    "measure": "Idiopathic Hypersomnia Severity Scale (IHSS)",
                    "description": "Change in total IHSS score",
                    "timeFrame": "End of stable dose visit to end of double-blind, randomized withdrawal visit [Week 12 to Week 14; 2 week period]"
                },
                {
                    "measure": "Clinical Global Impression of change (CGI-C)",
                    "description": "Worsening of idiopathic hypersomnia symptoms as assessed by clinician",
                    "timeFrame": "End of stable dose visit to end of double-blind, randomized withdrawal visit [Week 12 to Week 14; 2 week period]"
                },
                {
                    "measure": "Functional Outcomes of Sleep Questionnaire (FOSQ-10)",
                    "description": "Change in total FOSQ-10 score",
                    "timeFrame": "End of stable dose visit to end of double-blind, randomized withdrawal visit [Week 12 to Week 14; 2 week period]"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Primary diagnosis of idiopathic hypersomnia\n* Total ESS score at Screening and Baseline \\> 11 if not on prior oxybate\n* Average nightly total sleep time of \\> 7 hours\n* May use stimulants/alerting agents but dose and regimen must have been stable for 2 months prior to Screening, and remain stable until the double-blind, randomized withdrawal visit\n* Females of childbearing potential must use highly effective contraception for 2 months prior to Baseline, throughout the study, and for 30 days after the last dose of study drug\n* Males with female partners of childbearing potential must use condoms throughout the study and for 30 days after the last dose of study drug\n* Willing and able to provide informed consent and comply with the requirements of the study\n\nExclusion Criteria:\n\n* Pregnant, nursing or lactating females\n* Hypersomnia due to another medical, behavioral, sleep, or psychiatric condition\n* Untreated or incompletely treated sleep apnea in patients with an apnea-hypopnea index (AHI) \u2265 15 by American Academy of Sleep Medicine (AASM) 1A criteria\n* Clinically significant parasomnias\n* History or presence of seizures, head trauma, succinic semialdehyde dehydrogenase deficiency, uncontrolled hypothyroidism, and/or significant hepatic impairment\n* History or presence of bipolar and related disorders, schizophrenia, schizophrenia spectrum disorders, or other psychotic disorders\n* Ongoing or past (within 1 year) major depressive episode\n* At risk for suicide or history of suicide attempt\n* Treatment or planned treatment with any central nervous system (CNS) sedating agents\n* Current or past substance use disorder (including alcohol or cannabinoids)\n* Excessive caffeine consumption (\\> 600 mg/day)\n* Prior treatment with either FT218 or LUMRYZ",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "75 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Gretchen Richards, MS",
                    "role": "CONTACT",
                    "phone": "(636) 449-1830",
                    "email": "grichards@avadel.com"
                },
                {
                    "name": "Gina Leone, RN, BSN",
                    "role": "CONTACT",
                    "email": "gleone.ext@avadel.com"
                }
            ],
            "locations": [
                {
                    "facility": "Alpine Clinical Research Center",
                    "status": "RECRUITING",
                    "city": "Boulder",
                    "state": "Colorado",
                    "zip": "80301",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Sharon Beck",
                            "role": "CONTACT"
                        },
                        {
                            "name": "John Harsh, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.01499,
                        "lon": -105.27055
                    }
                },
                {
                    "facility": "Florida Pediatric Institute",
                    "status": "RECRUITING",
                    "city": "Winter Park",
                    "state": "Florida",
                    "zip": "32789",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Heidi Patenaude",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Akinyemi Ajayi, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 28.6,
                        "lon": -81.33924
                    }
                },
                {
                    "facility": "Clinical Research Institute",
                    "status": "RECRUITING",
                    "city": "Stockbridge",
                    "state": "Georgia",
                    "zip": "30281",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Beverley Jenkins",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Phillip Nowlin, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.54428,
                        "lon": -84.23381
                    }
                },
                {
                    "facility": "Clinical Neurophysiology Services PC",
                    "status": "RECRUITING",
                    "city": "Sterling Heights",
                    "state": "Michigan",
                    "zip": "48314",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jessica Austin",
                            "role": "CONTACT"
                        },
                        {
                            "name": "R. Bart Sangal, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.58031,
                        "lon": -83.0302
                    }
                },
                {
                    "facility": "Advanced Respiratory and Sleep Medicine",
                    "status": "RECRUITING",
                    "city": "Huntersville",
                    "state": "North Carolina",
                    "zip": "28078",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Felix Kumiawan",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Thomas Stern, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.41069,
                        "lon": -80.84285
                    }
                },
                {
                    "facility": "Bogan Sleep Consultants",
                    "status": "RECRUITING",
                    "city": "Columbia",
                    "state": "South Carolina",
                    "zip": "29201",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Heather Byrd, RPSGT",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Richard Bogan, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.00071,
                        "lon": -81.03481
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000006970",
                    "term": "Disorders of Excessive Somnolence"
                },
                {
                    "id": "D000020177",
                    "term": "Idiopathic Hypersomnia"
                }
            ],
            "ancestors": [
                {
                    "id": "D000020919",
                    "term": "Sleep Disorders, Intrinsic"
                },
                {
                    "id": "D000020920",
                    "term": "Dyssomnias"
                },
                {
                    "id": "D000012893",
                    "term": "Sleep Wake Disorders"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000001523",
                    "term": "Mental Disorders"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M22006",
                    "name": "Idiopathic Hypersomnia",
                    "asFound": "Idiopathic Hypersomnia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10021",
                    "name": "Disorders of Excessive Somnolence",
                    "asFound": "Hypersomnia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1717",
                    "name": "Sleepiness",
                    "relevance": "LOW"
                },
                {
                    "id": "M22242",
                    "name": "Parasomnias",
                    "relevance": "LOW"
                },
                {
                    "id": "M22654",
                    "name": "Sleep Disorders, Intrinsic",
                    "relevance": "LOW"
                },
                {
                    "id": "M22655",
                    "name": "Dyssomnias",
                    "relevance": "LOW"
                },
                {
                    "id": "M15696",
                    "name": "Sleep Wake Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M4815",
                    "name": "Mental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14473",
                    "name": "Psychotic Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "T2999",
                    "name": "Idiopathic Hypersomnia",
                    "asFound": "Idiopathic Hypersomnia",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M15780",
                    "name": "Sodium Oxybate",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "AdjAn",
                    "name": "Adjuvants, Anesthesia"
                },
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}